EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, DexCom's Enterprise Value is $33,150 Mil.
DexCom's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 was $750 Mil. Therefore, DexCom's EV-to-EBIT for today is 44.21.
The historical rank and industry rank for DexCom's EV-to-EBIT or its related term are showing as below:
DXCM'
s EV-to-EBIT Range Over the Past 10 Years
Min: -559.89 Med: 56.7 Max: 414.55
Current: 44.21
During the past 13 years, the highest EV-to-EBIT of DexCom was 414.55. The lowest was -559.89. And the median was 56.70.
DXCM's EV-to-EBIT is ranked worse than 79.96% of 459
companies
in the Medical Devices & Instruments industry
Industry Median: 20.09
vs DXCM: 44.21
The historical data trend for DexCom's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, DexCom's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DexCom's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, DexCom's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where DexCom's EV-to-EBIT falls into.
DexCom's current Enterprise Value is $33,150 Mil.
DexCom's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $750 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DexCom (NAS:DXCM) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
DexCom's Enterprise Value for the quarter that ended in Mar. 2025 was $26,659 Mil.
DexCom's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $750 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DexCom EV-to-EBIT Related Terms
Thank you for viewing the detailed overview of DexCom's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
DXCM has been successfully added to your 